Sal Churi: If you’re competing with countries with strategic subsidies, you can’t just “free market” your way to profitability. Pharma is a clear example. If China is subsidizing drug development and US companies want to compete, they have to do at prices that cannot compare. How do you think about balancing deregulation, with targeted subsidies?
From Twitter
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments
Share
Relevant content




